Cross-Sector entity
Amy Arnott is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is leadership: 1 of 3 stories, with the rest divided among 2 other categories. Each carries 3 original sources on average.
3 verified stories tracked
Last mentioned: Mar 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Amy Arnott is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is leadership: 1 of 3 stories, with the rest divided among 2 other categories. Each carries 3 original sources on average. We currently track 3 Cross-Sector stories that mention Tempus AI Inc., all published on March 16, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tempus AI Inc.. Shared-story counts are live from our verified record — not editorial picks.
ARK Invest CEO Cathie Wood has increased her position in Tempus AI with a $2 million purchase, signaling continued conviction in AI-driven healthcare despite a 15% year-to-date decline. This move comes as Wood's flagship ARKK fund faces renewed pressure, trailing the S&P 500 significantly over a five-year horizon.
ARK Invest CEO Cathie Wood has increased her stake in Tempus AI with a $2 million purchase, signaling continued conviction in high-growth technology despite a 15% year-to-date decline for the stock. This move comes as her flagship Ark Innovation ETF struggles to keep pace with the broader market, currently trailing the S&P 500 as Wood maintains her stance that the AI sector is far from a bubble.
Cathie Wood's ARK Investment Management has purchased $2 million worth of Tempus AI shares, reinforcing its position in the precision medicine firm despite a 15% year-to-date decline. The move underscores Wood's commitment to 'coiled spring' AI and biotech assets, even as her flagship funds face significant performance headwinds compared to the broader market.
Source: Kansascity · Miamiherald
